Moderna files quarterly report (10-Q) for the period ended Sep 30, 2025

Moderna filed its quarterly report on Form 10-Q with the SEC on Nov 6, 2025, 4:05 PM ET, covering the quarter ended Sep 30, 2025. It reports fiscal Q3 2025 results.

• Revenue: $1.02B (−45.4% from $1.86B a year earlier)
• Operating income: −$260.0M (vs −$70.0M a year earlier)
• Net income: −$200.0M (vs $13.0M a year earlier)
• Diluted EPS: $-0.51 (vs $0.03 a year earlier)
• Form 10-Q accepted by EDGAR Nov 6, 2025, 4:05 PM ET
• Accession number 0001682852-25-000075

SEC filing 10-Q · accession 0001682852-25-000075 · sec.gov ↗